Spotlight Therapeutics is pioneering cell-targeted in vivo CRISPR gene editing by creating a new class of programmable ribonuceloproteins called Targeted Active Gene Editors (TAGE). These modular biologic constructs are engineered to overcome the current limitations of viral and nanoparticle delivery.
# of employees: 11-50
Industry: Gene Therapy
Location: Hayward, CA
Having a single person responsible for managing a spreadsheet-based inventory system was prone to human error and created bottlenecks.
It was difficult to run large-scale analyses across sets of experiments. Data lacked the structure and standardization necessary for big data analytics.
Unconnected note-taking, lab management, and data interpretation systems encouraged siloed work rather than collaborative work.